While complete HSP60 knockout in specific tissues or organs leads to diseases and death in animal models and humans [11–14], low HSP60 expression has been observed in various diseases, including sarcopenia [15], diabetes [16, 17], heart failure [18, 19], neurodegenerative diseases [20], and some types of cancers [21]. Here, HSPD1 is linked to sarcopenia.